Process development for large scale synthesis of conjugated materials for electronic application can be challenging owing to the sensitivity of the syntheses for C-C coupling reaction. Herein, we present Seqen's expertise in synthesis and process optimization of such materials, with a roadmap for fast track commercialization from lab to fab.

Andreanne Bolduc got her Ph.D in chemical development of small molecules for organic electronics in 2014 at the University of Montreal, Canada. Her studies led her to do a postdoctoral fellowship in the Technical University of Eindhoven in the Netherlands on low bandgap polymers for OPV applications. She has worked as a research and development chemist at Seqens from February 2016 to February 2019, where she became Sales and Marketing Manager for the electronic market.

Novacap and all its activities unified under one new name and become SEQENS. SEQENS is an integrated global leader in pharmaceutical synthesis and specialty ingredients, delivering outstanding performance, unrivalled market responsiveness and tailor-made solutions to our customers.